XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.23.1

Common Stock and Employee Equity Plans | 3 Months Ended
--- | ---
Apr. 01, 2023
Equity [Abstract] |
Common Stock and Employee Equity Plans | Common Stock and Employee Equity Plans Common Stock Shares of common stock outstanding were as follows:
|  |  | Three Months Ended
|  |  |  |  | April 1, 2023 |  | March 26, 2022
|  |  |  |  | (In millions)
Balance, beginning of period |  |  |  |  | 1,612 |  |  | 1,207 |
Common stock issued in the acquisition of Xilinx |  |  |  |  | — |  |  | 429 |
Common stock issued under employee equity plans |  |  |  |  | 1 |  |  | 1 |
Common stock repurchases for tax withholding on equity awards |  |  |  |  | (1) |  |  | (1) |
Repurchases of common stock |  |  |  |  | (3) |  |  | (16) |
Balance, end of period |  |  |  |  | 1,609 |  |  | 1,620 |
Stock Repurchase Program In May 2021, the Company’s Board of Directors approved a stock repurchase program authorizing repurchases of up to $4 billion of the Company’s common stock (Existing Repurchase Program). In February 2022, the Company’s Board of Directors approved a new stock repurchase program in addition to the Existing Repurchase Program to purchase up to $8 billion of outstanding common stock in the open market (collectively referred to as the “Repurchase Program”). During the three months ended April 1, 2023, the Company returned $241 million to shareholders through the repurchase of 3.0 million shares of its common stock under the Repurchase Program. As of April 1, 2023, $6.3 billion remains available for future stock repurchases under the Repurchase Program. The Repurchase Program does not obligate the Company to acquire any common stock, has no termination date and may be suspended or discontinued at any time. Stock-based Compensation Stock-based compensation expense recorded in the Condensed Consolidated Statements of Operations was as follows:
|  |  | Three Months Ended
|  |  |  |  | April 1, 2023 |  | March 26, 2022
|  |  |  |  | (In millions)
Cost of sales |  |  |  |  | $ | 8 |  |  | $ | 4 |
Research and development |  |  |  |  | 214 |  |  | 113 |
Marketing, general and administrative |  |  |  |  | 87 |  |  | 82 |
Total |  |  |  |  | $ | 309 |  |  | $ | 199 |
During the three months ended April 1, 2023 and March 26, 2022, the Company recorded $4 million and $25 million of acquisition-related stock-based compensation expense under post-acquisition service conditions.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration